Best Single Time Point Correlations with AUC for Cyclosporine and Tacrolimus in HIV-Infected Kidney and Liver Transplant Recipients. Transplantation, 97, 702-707. presented at the 03/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24389906. (2014).
Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV-HIV Coinfected Liver Transplant Recipients. Am J Transplant, 14, 1129-1135. presented at the 05/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24636466. (2014).
Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients. Am J Transplant, 14(5), 1129-35. presented at the 2014 May. doi:10.1111/ajt.12668. (2014).
Changes in Clearance, Volume and Bioavailability of Immunosuppressants When Given With HAART in HIV-1 Infected Liver and Kidney Transplant Recipients. Biopharm Drug Dispos, 34, 442-451. presented at the 11/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24030928. (2013).
Surgical Complications in 275 HIV-Infected Liver and/or Kidney Transplantation Recipients. Surgery, 152, 376-381. presented at the 09/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22938898. (2012).
The best single time point measurement correlations with AUC for cyclosporine and tacrolimus in HIV-1 infected liver and kidney transplant recipients (poster session). In World Congress of Nephrology. presented at the 09/04/2011, Vancouver, Canada. Retrieved from http://www.abstracts2view.com/wcn/view.php?nu=WCN11L_619&terms=. (2011).
BK virus is not a significant cause of graft loss in HIV+ kidney recipients (oral presentation). In . presented at the 2011, Philadelphia, PA. Retrieved from http://www.abstracts2view.com/atc/view.php?nu=ATC11L_498&terms=. (2011).
HIV-Related Predictors and Outcomes in 275 Liver and/or Kidney Transplant Recipients (oral presentation). In . presented at the 2011, Philadelphia, PA. Retrieved from http://www.abstracts2view.com/atc/view.php?nu=ATC11L_377&terms=. (2011).
Tenofovir is not associated with renal dysfunction following solid organ transplantation. In . presented at the 2011, Philadelphia, PA. Retrieved from http://www.abstracts2view.com/atc/view.php?nu=ATC11L_857&terms=. (2011).
MELD (The Model for End-Stage Liver Disease (MELD)) Score Is an Important Predictor of Pretransplantation Mortality in HIV-Infected Liver Transplant Candidates. Gastroenterology, 138, 159-164. presented at the 01/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19800334. (2010).
Outcomes of Kidney Transplantation in HIV-Infected Recipients. N Engl J Med, 363, 2004-2014. presented at the 11/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?term=21083386. (2010).
Treatment-Dependent Loss of Polyfunctional Cd8+ T-Cell Responses in HIV-Infected Kidney Transplant Recipients Is Associated with Herpesvirus Reactivation. Am J Transplant, 9, 794-803. presented at the 04/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19298451. (2009).
Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation. Am J Transplant, 9(4), 794-803. presented at the 2009 Apr. doi:10.1111/j.1600-6143.2008.02539.x. (2009).
HIV-Infected Liver and Kidney Transplant Recipients: 1- and 3-Year Outcomes. Am J Transplant, 8, 355-365. presented at the 02/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18093266. (2008).